Radio and PodcastLive Radio & PodcastsScience & Medicine
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is an episode from New...
About This Episode
151 - PU-H71 for myelofibrosis; RGX-111 for Mucopolysaccharidosis; Moxidectin For The Treatment Of River Blindness; Wearable Device to Treat Opioid Addiction; FDA Clearance For Thrombectomy Device is an episode from New FDA Approvals. This...
Podcast
This episode belongs to New FDA Approvals.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jun 14, 2018, 15:58 long, audio available.
Related Episodes
Continue listening to more episodes from New FDA Approvals.